Coronavirus Coverage

UA COVID-19 Test Tracker

Daily (12/8)
669 11 1.6%
Total (8/2)
66,070 1,065 1.6%
Includes tests since August 2, 2021
Data from https://covid19.arizona.edu/updates
Updated December 8, 2021

Knocking down the COVID-19 disparities through university community partnerships

11/19/2020 4:57pm

The University of Arizona, in partnership with Arizona State University, Northern Arizona University and the Mayo Clinic in Scottsdale, made Arizona one of the 11 states that are participating in the National Institute of Health’s Community Engagement Alliance Against COVID-19 Disparities. With a $1 million-a-year grant, the Arizona CEAL COVID Consortium is working with over 30 community leaders and organizations to identify and combat COVID-19-related health disparities.

Moderna releases interim coronavirus vaccine data, over 94% effective

02/16/2022 10:35am

The pandemic, which has resulted in over 55 million infections and 1.3 million deaths worldwide, has started to result in major fatigue, demonstrated by daily case counts across the U.S. touching 200,000. About a week after Pfizer released early coronavirus vaccine data, Moderna — a biotechnology company based in Massachusetts — released its early results. The data shows that the vaccine is more than 94% effective.

Should professors be more lenient with assignments due to stress and anxiety?

11/12/2020 11:50am

It should come as no surprise that anxiety disorders are the most common mental illness in the United States. The Anxiety and Depression Association of America has stated that anxiety disorders are affecting approximately 40 million adults in the United States. This translates to having 18.1 percent of the United States population being diagnosed, with only 36.9 percent of that cohort receiving treatment.

Business owners reflect on cancellation of Fourth Avenue's Winter Street Fair

11/04/2020 12:25pm

 As the annual winter event brings in nearly 400,000 guests each year, the street fair would not be meeting the necessary protocol guidelines instituted by the Pima County Health Department according to the Historic Fourth Avenue website.  This was disappointing news for not only the many guests who attend, but for the artists, vendors, sponsors and local merchants who depend greatly on this event to boost their businesses. 

OPINION: Goodbye spring break

10/30/2020 7:57am

The University of Arizona's Office of the Provost announced the cancellation of spring break 2021 and has opted for seemingly randomized days off throughout the semester which they've woefully titled "reading days" — there is frustration from every part of the UA community.

Comparing and contrasting the influenza virus and coronavirus

10/27/2020 9:54am

With COVID-19 cases now on the rise across the United States, worries of flu season have also come up, especially with it being right around the corner. Their striking similarities may be hard to point out from each other; however, telltale signs can easily differentiate them.

COVID-19 complicates efforts against domestic violence

10/27/2020 2:11pm

Every minute, 20 people suffer physical abuse from their partners according to the National Coalition Against Domestic Violence. The pandemic may have slowed economic trends, but unfortunately the domestic violence clock ticks on. Most concerning are the effects social distancing and quarantine measures have had on victim outreach rates. 

EDITORIAL: Cancelling Spring Break was not the right move

10/22/2020 11:41pm

On Oct. 14, Provost Liesl Folks sent an email officially cancelling Spring Break for the 2021 spring semester. Citing efforts to “limit the spread of COVID-19,” the university replaced the week-long break with a series of five reading days spread out throughout the semester, with one in February, two in March and two in April, with only March 9 and 10 being on consecutive days. This development has sparked the Opinions Board at the Daily Wildcat to put together a statement on not only the Spring Break decision, but also health in the time of online school in general. 

Antiviral drug remdesivir becomes first approved treatment for COVID-19

10/22/2020 5:56pm

On Thursday, Oct. 22, the antiviral drug, remdesivir, received a full approval from the U.S. Food and Drug Administration, making it the first official and approved treatment for COVID-19. The drug, sold under the brand name Veklury, has been used under an emergency use authorization which was issued back in May.